Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Water → N-1,2-Benzisoxazol-3-yl-4-(3-morpholin-4-yl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Water | HCID 962 | — |
| 반응물 | Triethylamine | HCID 8471 | — |
| 반응물 | 4-(5-Chloro-1,2,4-thiadiazol-3-yl)morpholine | HCID 56832319 | — |
| 반응물 | N-1,2-Benzisoxazol-3-ylpiperazine-1-carboxamide trifluoroacetate | HCID 68778018 | — |
| 용매 | Dimethylformamide | HCID 6228 | — |
| 생성물 | N-1,2-Benzisoxazol-3-yl-4-(3-morpholin-4-yl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide | HCID 68781122 | 38.8% |
반응 단계
To a solution of 4-(5-chloro-1,2,4-thiadiazol-3-yl)morpholine (114 mg, 0.555 mmol) and N-1,2-benzisoxazol-3-ylpiperazine-1-carboxamide trifluoroacetate (200 mg, 0.555 mmol) in N,N-dimethylformamide (2 ml) was added triethylamine (0.389 ml, 2.78 mmol) at room temperature, and the mixture was stirred at room temperature for 1 hour. The reaction mixture was poured to water, and the precipitated solid was separated by filtration, which was recrystallized from a mixed solvent of methanol, ethyl acetate and tetrahydrofuran to give 89.4 mg (38.7%) of the desired product.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07851473B2 |
| 출처 데이터셋 | uspto-grants-2010_12 |
| ORD ID | ord-2b6f4a2eaeb6415d9d4f2d6b70dd4ed2 |
| 출처 메모 | uspto-grants-2010_12 |